Pfizer Sues Ranbaxy, Teva Over Accupril Patent
Pfizer Inc. has sued India's Ranbaxy and Israel's Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril....To view the full article, register now.
Already a subscriber? Click here to view full article